| 000 | 01715 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512092102.0 | ||
| 264 | 0 | _c19740906 | |
| 008 | 197409s 0 0 eng d | ||
| 022 | _a0012-6667 | ||
| 024 | 7 |
_a10.2165/00003495-197407010-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGibson, D G | |
| 245 | 0 | 0 |
_aPharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. _h[electronic resource] |
| 260 |
_bDrugs _c1974 |
||
| 300 |
_a8-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAlprenolol _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aCatecholamines _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlycolysis _xdrug effects |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aOxprenolol _xpharmacology |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 | _aPhysical Exertion |
| 650 | 0 | 4 |
_aPindolol _xpharmacology |
| 650 | 0 | 4 |
_aPractolol _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aQuinidine _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xdrug effects |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aVasomotor System _xdrug effects |
| 773 | 0 |
_tDrugs _gvol. 7 _gno. 1 _gp. 8-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-197407010-00002 _zAvailable from publisher's website |
| 999 |
_c4157148 _d4157148 |
||